Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Psychiatric Disorders: early-phase trial registry
3 of 4 indexed Psychiatric Disorders trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Psychiatric Disorders: 4 US clinical trials tracked, 3 recruiting.
Psychiatric Disorders is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cambridge Health Alliance, running 1 of these trials.
Enrollment posture brief
Registry condition psychiatric-disorders
OPEN 3 | RECR 75% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Psychiatric Disorders lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Psychiatric Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Psychiatric Disorders is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Treatment for Individuals Interacting with the Criminal Justice System
Cambridge Health Alliance
NCT06564948
Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety
National Institute of Mental Health (NIMH)
NCT06595953
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
University of Pittsburgh
NCT07043803
CYP2D6 Pharmacogenetics in Risperidone-Treated Children
Children's Hospital Medical Center, Cincinnati
NCT00783783
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Psychiatric Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Psychiatric Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Psychiatric Disorders page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Psychiatric Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cambridge Health Alliance sponsors the most Psychiatric Disorders trials on record, review their full trial history before evaluating a specific study. See Cambridge Health Alliance's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Psychiatric Disorders condition card totals 4 registered trials; most-linked intervention Reduction of anticholinergic medication; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.